CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Large Decrease in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a significant decline in short interest in July. As of July 31st, there was short interest totalling 100 shares, a decline of 50.0% from the July 15th total of 200 shares. Based on an average daily trading volume, of 172,600 shares, the short-interest ratio is currently 0.0 days.

CNBX Pharmaceuticals Stock Up 42.3 %

CNBX traded up $0.00 on Tuesday, reaching $0.01. The stock had a trading volume of 65,522 shares, compared to its average volume of 226,539. CNBX Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.05. The business’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.